Meds@HOME App to Support Medication Safety

Medication Errors and Other Product Use Errors and Issues Clinical Trial

Official title:

Meds@HOME - Improving Medication Safety for Medically Complex Children With mHealth Across Caregiving Networks (R18 Aim 2)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05816590
• Other study ID #: 2022-1620
• Secondary ID: Protocol Version
• Status: Recruiting
• Phase: N/A
• Start date: December 11, 2023
• Est. completion date: May 2025

Study information

• Verified date: December 2023
• Source: University of Wisconsin, Madison
• Contact: Gemma Warner
• Phone: (608) 263-0740
• Email: gwarner[@]pediatrics.wisc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study determines whether the mHealth intervention, Meds@HOME, helps caregivers improve medication administration to Children with Medical Complexity (CMC) who use high-risk medications. A total of 152 primary caregivers, 152 children, and up to 304 secondary caregivers will be recruited and can expect to be on study for up to 6 months.

Description:

The investigators will test the hypothesis that Meds@HOME use improves medication administration accuracy for caregivers by conducting a 6-month randomized controlled trial with caregivers of CMC. The study population will consist of 1) CMC who are prescribed at least one scheduled high-risk medication and receive care at UW Health, and 2) their caregivers. The study distinguishes between three types of caregivers: 1) primary caregivers (child's parent or legal guardian), 2) secondary caregivers (up to 2 individuals who regularly provide care for the child and who complete study surveys), and 3) other caregivers (invited to use the app but not complete study surveys). CMC and their primary caregiver participants will be randomized into intervention (Meds@HOME, "I") or control ("C") groups. Assessments at baseline and 6 months post-enrollment will assess the primary endpoint (medication administration accuracy), secondary outcomes, and Meds@HOME use by primary and secondary caregivers. Participant accrual will occur over 12 months at one site and participants can expect to be on study for 6 months. The primary study objective is to evaluate the effectiveness of Meds@HOME on primary caregiver medication administration accuracy. The secondary objectives are to evaluate Meds@HOME's: - effectiveness on secondary caregiver medication administration accuracy - effect on adverse drug event (ADE) hospital use - effect on adverse drug event ED use - effect on parent-reported medication adherence - effect on parent-reported medication activation - effect on parent-reported medication confidence - effect on parent-reported medication understanding - effect on all-cause hospital use - effect on all-cause ED use - effect on mortality - effect on the primary outcome measured as 5 individual components

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 304
• Est. completion date: May 2025
• Est. primary completion date: May 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria (Child with Medical Complexity):

• less than or equal to 17 years of age at start of study
• In the last 12 months, child has had at least two or more encounters (in-person or telehealth clinic visit, ED visit, or hospital admission) in the UWHC/AFCH system
• Child has 2 or more different complex chronic conditions
• Child has at least 1 active, outpatient prescription for a scheduled high-risk medication
• Provided assent, if appropriate

Inclusion Criteria (Primary Caregiver):

• Provided written informed consent form as the child's parent or legal guardian
• Willing to comply with all study procedures and available for the duration of the study
• At least 18 years of age
• Comfortable speaking and reading in English
• Self-identifies as a primary caregiver of a study-eligible CMC
• Currently provides care on an ongoing basis to the study-eligible CMC. Child may not be housed in a skilled nursing facility, an acute care or transitional facility, a rehabilitative hospital, or in a medical group home
• Has iOS or Android mobile device (smartphone, tablet) with a phone plan that includes daily Wi-Fi service and data

Inclusion Criteria (Secondary Caregiver):

• Has been identified as a "secondary caregiver" by the primary caregiver
• Provided informed consent
• Willing to comply with all study procedures and be available for the duration of the study
• At least 18 years of age
• Comfortable speaking and reading in English
• Currently provides care on an ongoing basis to the study-eligible CMC
• Administers medications to the study-eligible CMC
• Has an iOS or Android mobile device (smartphone) with a phone plan that includes daily Wi-Fi service and data

Inclusion Criteria (Other Caregivers - Treatment Group only):

• Has been identified by a primary caregiver assigned to the intervention group as a person providing care to the child
• Has been invited by the primary caregiver to use the app (i.e., sent email invitation via Meds@HOMEapp)
• Signed up to become a Meds@HOME user by clicking on link in email invitation and completing user registration
• Is not participating in study survey data collection as a secondary caregiver

Exclusion Criteria:

• Failure to meet all inclusion criteria
• Another child from the household is already enrolled in the study

Related Conditions & MeSH terms

• Medication Errors and Other Product Use Errors and Issues

Intervention

Other:
• Med@HOME Mobile App
Meds@HOME is a software application designed for use on a personal mobile device. The app allows primary caregiver to create routines where they can detail how to perform the routine, start date and time, and frequency (daily, weekly, monthly). Optional push notifications can be set so that users are alerted to an upcoming routine. Only primary caregivers can create, edit, and delete routines. All caregivers can check off on routines and receive notifications. Caregivers can also post notes related to routines or events. App enables an inventory of caregiver troubleshooting strategies and inventory reminders.

Locations

Country	Name	City	State
United States	University of Wisconsin-Madison, UW Health	Madison	Wisconsin

Sponsors (2)

Lead Sponsor	Collaborator
University of Wisconsin, Madison	Agency for Healthcare Research and Quality (AHRQ)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Percentage of Participants Demonstrating Medication Administration Accuracy	Rate of medication administration accuracy, measured dichotomously as correct identification of each of the following for a randomly selected high risk medication: indication, formulation, dose, frequency, and route after 6-months	baseline (before randomization), 6 months
Secondary	Change in Percentage of Participants Demonstrating Medication Administration Accuracy among Secondary Caregivers	Rate of medication administration accuracy, measured as in the primary outcome, amongst secondary caregivers after 6-months	baseline (before randomization), 6 months
Secondary	Count of University of Wisconsin (UW) hospital encounters during study period with Adverse Drug Event (ADE) codes		up to 6 months
Secondary	Count of UW Emergency Department (ED) encounters during study period with ADE codes		up to 6 months
Secondary	Mean parent-reported medication adherence using the Adherence to Refills and Medications Scale (ARMS)	ARMS is a 12-item instrument scored from 12 to 34, with lower scores indicating better adherence.	up to 6 months
Secondary	Mean FCAT (Family Caregiver Activation in Transition) Score for 5 medication-specific items	FCAT Score for 5 medication-specific items - composite and individual items will be reported after 6-months. Scoring is from 1-5 with higher scores indicating fewer challenges to care.	up to 6 months
Secondary	Parent-Reported Medication Confidence	To evaluate Meds@HOME's effect on parent-reported medication confidence. Mean composite score after 6-months. Medication Confidence is measured on a 7-item survey scored on a 5 point likert scale for a total possible range of scores from 7-35 where lower scores indicate increased medication confidence.	up to 6 months
Secondary	Parent-Reported Medication Understanding	To evaluate Meds@HOME's effect on parent-reported medication understanding. Mean composite score after 6-months. Medication Understanding is measured on a 5-item survey scored on a 5 point likert scale for a total possible range of scores from 5-25 where lower scores indicate increased medication understanding.	up to 6 months
Secondary	Count of hospital encounters and hospital days during study period	Count of hospital encounters and hospital days during study period.	up to 6 months
Secondary	Count of ED encounters during study period	Count of ED encounters during study period.	up to 6 months
Secondary	Count of deaths during the study period	Count of deaths during the study period	up to 6 months
Secondary	Rate of Medication Adherence for Individual Components (indication, formulation, dose, frequency, and route)	Rate of individual components each measured dichotomously (indication, formulation, dose, frequency, and route).	up to 6 months
Secondary	Mean Number of Individual Components of Medication Adherence Correct	Mean number of individual components correct (from 0 components to all 5: indication, formulation, dose, frequency, route).	up to 6 months